---
input_text: 'Cerebral hemodynamics and oxygenation in adult patients with sickle cell
  disease after stem cell transplantation. Sickle cell disease (SCD) is characterized
  by chronic hemolytic anemia associated with impaired cerebral hemodynamics and oxygen
  metabolism. Hematopoietic stem cell transplantation (HSCT) is currently the only
  curative treatment for patients with SCD. Whereas normalization of hemoglobin levels
  and hemolysis markers has been reported after HSCT, its effects on cerebral perfusion
  and oxygenation in adult SCD patients remain largely unexplored. This study investigated
  the effects of HSCT on cerebral blood flow (CBF), oxygen delivery, cerebrovascular
  reserve (CVR), oxygen extraction fraction (OEF), and cerebral metabolic rate of
  oxygen (CMRO2 ) in 17 adult SCD patients (mean age: 25.0 +- 8.0, 6 females) before
  and after HSCT and 10 healthy ethnicity-matched controls (mean age: 28.0 +- 8.8,
  6 females) using MRI. For the CVR assessment, perfusion scans were performed before
  and after acetazolamide as a vasodilatory stimulus. Following HSCT, gray and white
  matter (GM and WM) CBF decreased (p < .01), while GM and WM CVR increased (p < .01)
  compared with the baseline measures. OEF and CMRO2 also increased towards levels
  in healthy controls (p < .01). The normalization of cerebral perfusion and oxygen
  metabolism corresponded with a significant increase in hemoglobin levels and decreases
  in reticulocytes, total bilirubin, and LDH as markers of hemolysis (p < .01). This
  study shows that HSCT results in the normalization of cerebral perfusion and oxygen
  metabolism, even in adult patients with SCD. Future follow-up MRI scans will determine
  whether the observed normalization of cerebral hemodynamics and oxygen metabolism
  prevents new silent cerebral infarcts.'
raw_completion_output: |-
  primary_disease: Sickle cell disease (SCD)
  medical_actions: Hematopoietic stem cell transplantation (HSCT); MRI scans; perfusion scans with acetazolamide
  symptoms: Chronic hemolytic anemia; impaired cerebral hemodynamics; impaired oxygen metabolism
  chemicals: Acetazolamide; Hemoglobin; Reticulocytes; Total Bilirubin; LDH
  action_annotation_relationships: Hematopoietic stem cell transplantation (HSCT) TREATS chronic hemolytic anemia IN Sickle cell disease (SCD); Hematopoietic stem cell transplantation (HSCT) TREATS impaired cerebral hemodynamics IN Sickle cell disease (SCD); Hematopoietic stem cell transplantation (HSCT) TREATS impaired oxygen metabolism IN Sickle cell disease (SCD); MRI scans DETECTS impaired cerebral hemodynamics IN Sickle cell disease (SCD); perfusion scans with acetazolamide MEASURES cerebrovascular reserve IN Sickle cell disease (SCD)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  perfusion scans with acetazolamide MEASURES cerebrovascular reserve IN Sickle cell disease (SCD)

  ===

extracted_object:
  primary_disease: MONDO:0007374
  medical_actions:
    - MAXO:0000747
    - MRI scans
    - perfusion scans with acetazolamide
  symptoms:
    - HP:0004870
    - impaired cerebral hemodynamics
    - impaired oxygen metabolism
  chemicals:
    - CHEBI:27690
    - CHEBI:35143
    - Reticulocytes
    - Total Bilirubin
    - LDH
  action_annotation_relationships:
    - subject: <Hematopoietic stem cell transplantation>
      predicate: <TREATS>
      object: <chronic hemolytic anemia>
      qualifier: <Sickle cell disease>
      subject_qualifier: <>
      object_qualifier: <>
      subject_extension: <Hematopoietic stem cell transplantation>
      object_extension: <>
    - subject: MAXO:0000747
      predicate: TREATS
      object: impaired cerebral hemodynamics
      qualifier: MONDO:0011382
    - subject: MAXO:0000747
      predicate: TREATS
      object: impaired oxygen metabolism
      qualifier: MONDO:0011382
    - subject: MRI scans
      predicate: DETECTS
      object: impaired cerebral hemodynamics
      qualifier: MONDO:0007374
      subject_qualifier: <null>
      object_qualifier: <null>
      subject_extension: <null>
      object_extension: <null>
    - subject: perfusion scans
      predicate: MEASURES
      object: cerebrovascular reserve
      qualifier: MONDO:0007374
      subject_qualifier: with acetazolamide
      subject_extension: CHEBI:27690
named_entities:
  - id: MONDO:0007374
    label: Sickle Cell Disease (SCD)
  - id: MAXO:0001479
    label: Allogeneic hematopoietic stem cell transplantation (allo-HSCT)
  - id: HP:0001923
    label: Increased reticulocyte counts
  - id: CHEBI:80240
    label: Endothelin-1
  - id: MONDO:0011382
    label: Sickle Cell Disease
  - id: HP:0001945
    label: fever
  - id: HP:0002754
    label: osteomyelitis
  - id: CHEBI:17334
    label: penicillin
  - id: MAXO:0000118
    label: immunization
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation
  - id: MAXO:0001001
    label: Gene therapy
  - id: MAXO:0009101
    label: Early intervention
  - id: HP:0000989
    label: pruritus
  - id: HP:0012393
    label: allergic reactions
  - id: HP:0012532
    label: chronic pain
  - id: HP:0007760
    label: SCD
  - id: MAXO:0001298
    label: therapy
  - id: CHEBI:6807
    label: Methadone
  - id: CHEBI:4027
    label: Cyclophosphamide
  - id: CHEBI:82557
    label: Treosulfan
  - id: MAXO:0000756
    label: Blood transfusions
  - id: HP:0012531
    label: Pain
  - id: CHEBI:44423
    label: Hydroxyurea
  - id: MONDO:0005632
    label: Acute Chest Syndrome
  - id: CHEBI:35480
    label: analgesics
  - id: CHEBI:49005
    label: Deferasirox
  - id: MONDO:0100096
    label: COVID-19
  - id: HP:0030157
    label: Flank pain
  - id: HP:0100749
    label: Chest pain
  - id: HP:0001878
    label: Hemolytic anemia
  - id: MONDO:0005570
    label: Hematological diseases
  - id: HP:0004444
    label: Spherocytosis
  - id: HP:0001028
    label: Hemangioma
  - id: HP:0001871
    label: Hematological diseases
  - id: MONDO:0017014
    label: children
  - id: HP:0030830
    label: crackles
  - id: HP:0002617
    label: Vasculopathy
  - id: MONDO:0005380
    label: Avascular necrosis
  - id: HP:0002829
    label: Joint pain
  - id: MAXO:0000586
    label: Invasive ventilation (not used)
  - id: MONDO:0006502
    label: Severe COVID-19 with acute respiratory distress syndrome (ARDS)
  - id: HP:0002094
    label: dyspnea
  - id: HP:0001873
    label: thrombocytopenia
  - id: MONDO:0003664
    label: Haemolytic anaemia
  - id: HP:0025435
    label: increased lactate dehydrogenase levels
  - id: HP:0011981
    label: pigment gallstones
  - id: HP:0001907
    label: thromboembolism
  - id: CHEBI:35341
    label: steroids
  - id: HP:0001890
    label: autoimmune haemolytic anaemia
  - id: MAXO:0000457
    label: Pain management
  - id: MAXO:0010030
    label: Bone marrow transplantation (BMT)
  - id: HP:0001297
    label: Stroke
  - id: CHEBI:28901
    label: Busulfan
  - id: CHEBI:4031
    label: Cyclosporine
  - id: CHEBI:61049
    label: Tacrolimus
  - id: CHEBI:44185
    label: Methotrexate
  - id: HP:0001903
    label: Anemia
  - id: MONDO:0021200
    label: rare diseases
  - id: CHEBI:8093
    label: Phenylephrine
  - id: CHEBI:50858
    label: corticosteroids
  - id: HP:0002902
    label: Hyponatremia
  - id: CHEBI:26708
    label: Sodium
  - id: MAXO:0001175
    label: Liver transplantation
  - id: MAXO:0001394
    label: oral administration
  - id: MONDO:0004992
    label: Cancer
  - id: CHEBI:125354
    label: plerixafor
  - id: MAXO:0000149
    label: Hematopoietic cell transplantation (HCT)
  - id: MAXO:0000087
    label: Massage
  - id: MAXO:0000010
    label: Cognitive behavioral therapy
  - id: HP:0012432
    label: Chronic fatigue
  - id: HP:0000739
    label: Anxiety
  - id: HP:0000716
    label: Depression
  - id: MONDO:0044348
    label: Hemoglobinopathies
  - id: HP:0000083
    label: Renal failure
  - id: HP:0004395
    label: Malnutrition
  - id: HP:0100806
    label: Sepsis
  - id: HP:0002090
    label: Pneumonia
  - id: HP:0002878
    label: Respiratory failure
  - id: CHEBI:50443
    label: Autologous hematopoietic stem cell (HSC)-based gene therapy
  - id: MONDO:0005775
    label: Glucose-6-phosphate dehydrogenase deficiency
  - id: CHEBI:29016
    label: arginine
  - id: CHEBI:68554
    label: deferiprone
  - id: HP:0012649
    label: Increased inflammatory response
  - id: CHEBI:9570
    label: Thiotepa
  - id: MONDO:0020380
    label: Sickle cell anemia (SCA)
  - id: HP:0002092
    label: Pulmonary hypertension
  - id: CHEBI:3216
    label: Buprenorphine
  - id: HP:0001139
    label: <Transcranial doppler (TCD) monitoring>
  - id: CHEBI:204928
    label: cefotaxime
  - id: HP:0001727
    label: Thromboembolic stroke
  - id: CHEBI:5588
    label: Hemoglobin A (HbA)
  - id: HP:0003095
    label: septic arthritis
  - id: HP:0002027
    label: abdominal pain
  - id: HP:0002013
    label: vomiting
  - id: HP:0001875
    label: neutropenia
  - id: HP:0012234
    label: agranulocytosis
  - id: CHEBI:4356
    label: deferoxamine
  - id: MONDO:0005354
    label: chronic hepatitis C
  - id: CHEBI:85083
    label: sofosbuvir
  - id: CHEBI:63580
    label: ribavirin
  - id: CHEBI:82977
    label: daclatasvir
  - id: CHEBI:85089
    label: ledipasvir
  - id: CHEBI:133009
    label: velpatasvir
  - id: CHEBI:132975
    label: grazoprevir
  - id: CHEBI:132967
    label: elbasvir
  - id: CHEBI:133008
    label: sofosbuvir/velpatasvir
  - id: CHEBI:17234
    label: glucose
  - id: HP:0200023
    label: Priapism
  - id: CHEBI:41879
    label: Dexamethasone
  - id: CHEBI:8764
    label: Mycophenolate mofetil
  - id: CHEBI:465284
    label: Ganciclovir
  - id: MONDO:0017291
    label: Reversible Cerebral Vasoconstriction Syndrome
  - id: CHEBI:9168
    label: Sirolimus
  - id: MONDO:0013730
    label: Graft-versus-host disease (GVHD)
  - id: CHEBI:2948
    label: azathioprine
  - id: CHEBI:33281
    label: antibiotics
  - id: MAXO:0000601
    label: dialysis
  - id: HP:0003774
    label: end-stage renal disease
  - id: CHEBI:17303
    label: Morphine
  - id: HP:0002326
    label: Transient ischaemic attacks
  - id: MAXO:0000068
    label: Transplantation
  - id: MAXO:0000427
    label: Brain magnetic resonance imaging
  - id: MAXO:0001259
    label: Angiography
  - id: HP:0011793
    label: Cerebral arteriopathy (CA)
  - id: MAXO:0000058
    label: drug treatment
  - id: CHEBI:10033
    label: warfarin
  - id: CHEBI:50249
    label: anticoagulants
  - id: HP:0004936
    label: venous thromboembolism (VTE)
  - id: HP:0004870
    label: Chronic hemolytic anemia
  - id: CHEBI:27690
    label: Acetazolamide
  - id: CHEBI:35143
    label: Hemoglobin
